Ashley Welch

All articles by Ashley Welch

• Advancements and gaps in HDFN care during pregnancy

  Despite advances in screening and treatment, HDFN remains a significant cause of perinatal morbidity and mortality worldwide.

• Researchers identify rare partial D variant that can lead to HDFN

  A newly found blood variant common in Indigenous Australians may raise HDFN risk by triggering anti-D antibodies.

• The role of pediatric hematologists in HDFN

  A pediatric hematologist has the expertise to help manage both immediate and long-term complications of HDFN.

• HDFN-affected families may face higher long-term healthcare costs

  A study showed children with HDFN needed more hospital care in their first year of life compared with those without the condition.

• Does HDFN risk still exist if a woman changes partners?

  Learn more about how the risk of HDFN in subsequent pregnancies is affected if the infants have different fathers.

• Rare blood type variant triggers severe case of HDFN

  The patient was found to have a partial D variant called DBT that is difficult to detect with standard serologic testing.

• How doctors decide when to stop IUTs before delivery

  Deciding when to stop IUTs requires balancing the risks of continuing the treatment versus the risks of delivering a premature baby.

• When are maternal antibodies the strongest during pregnancy?

  Learn more about when a baby receives the most maternal antibodies during pregnancy and how the antibodies are transferred to the fetus.

• Simple blood test technique helps find rare antibodies in HDFN

  A new case study emphasizes the importance of accurately identifying rare blood antibodies in pregnancy for the management of HDFN.

• Understanding fetal hemoglobin and its role in HDFN

  Fetal hemoglobin is a type of protein found in a baby’s blood before birth that carries oxygen from the mother’s bloodstream to the fetus.